Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Gross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

CollPlant Biotechnologies (CLGN) Depreciation & Amortization (IS) (2018 - 2025)

CollPlant Biotechnologies filings provide 8 years of Depreciation & Amortization (IS) readings, the most recent being $216000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (IS) fell 10.74% to $216000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $912000.0, a 12.14% decrease, with the full-year FY2025 number at $912000.0, down 12.14% from a year prior.
  • Depreciation & Amortization (IS) hit $216000.0 in Q4 2025 for CollPlant Biotechnologies, down from $223000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $294000.0 in Q4 2022 to a low of $173000.0 in Q1 2021.
  • Median Depreciation & Amortization (IS) over the past 5 years was $249500.0 (2024), compared with a mean of $245050.0.
  • Biggest five-year swings in Depreciation & Amortization (IS): soared 45.81% in 2022 and later dropped 14.79% in 2024.
  • CollPlant Biotechnologies' Depreciation & Amortization (IS) stood at $224000.0 in 2021, then soared by 31.25% to $294000.0 in 2022, then dropped by 3.4% to $284000.0 in 2023, then decreased by 14.79% to $242000.0 in 2024, then decreased by 10.74% to $216000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (IS) were $216000.0 (Q4 2025), $223000.0 (Q3 2025), and $229000.0 (Q2 2025) per Business Quant data.